Jaffetilchin Investment Partners’s VanEck Biotech ETF BBH Stock Holding History

Jaffetilchin Investment Partners’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-69	Closed	-$12.2K	–	456
2024 Q3	$12.2K	Buy	+69	New	+$12.2K	﹤0.01%	867
2023 Q1	–	Sell	-1,294	Closed	-$207K	–	355
2022 Q4	$207K	Buy	+1,294	New	+$205K	0.03%	327

Other funds holding BBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Jaffetilchin Investment Partners's BBH Position: Q4 2024 in Review

Jaffetilchin Investment Partners sold out of VanEck Biotech ETF (BBH) in Q4 2024, closing a stake of 69 shares — an estimated $12.2K sold.

Jaffetilchin Investment Partners first reported a position in BBH in Q4 2022 and held it in 2 quarters. The position peaked at $207K in Q4 2022. 115 funds tracked by Wall St. Rank hold BBH as of Q4 2024.

Jaffetilchin Investment Partners reported no remaining VanEck Biotech ETF position as of Q4 2024 after selling out during the quarter.
Jaffetilchin Investment Partners sold 69 VanEck Biotech ETF shares in Q4 2024, an estimated $12.2K.
Jaffetilchin Investment Partners first reported a position in VanEck Biotech ETF in Q4 2022 and held it in 2 quarters.
Jaffetilchin Investment Partners's VanEck Biotech ETF position peaked at $207K in Q4 2022.
115 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q4 2024.

Based on Jaffetilchin Investment Partners's 13F filing for Q4 2024, filed 13 Feb 2025.